|
1
|
Kristiansen C, Schytte T, Hansen KH,
Holtved E and Hansen O: Academy of Geriatric Cancer Research
(AgeCare): Trends in lung cancer in elderly in Denmark, 1980–2012.
Acta Oncol. 55(Suppl 1): 46–51. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Novaes FT, Cataneo DC, Ruiz RL Junior,
Defaveri J, Michelin OC and Cataneo AJ: Lung cancer: Histology,
staging, treatment and survival. J Bras Pneumol. 34:595–600. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tan BB, Flaherty KR, Kazerooni EA and
Iannettoni MD: American College of Chest Physicians: The solitary
pulmonary nodule. Chest. 123(Suppl 1): 89S–96S. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Winer-Muram HT: The solitary pulmonary
nodule. Radiology. 239:34–49. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gould MK, Sanders GD, Barnett PG, Rydzak
CE, Maclean CC, McClellan MB and Owens DK: Cost-effectiveness of
alternative management strategies for patients with solitary
pulmonary nodules. Ann Intern Med. 138:724–735. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schrevens L, Lorent N, Dooms C and
Vansteenkiste J: The role of PET scan in diagnosis, staging, and
management of non-small cell lung cancer. Oncologist. 9:633–643.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Spiro SG, Gould MK and Colice GL: American
College of Chest Physicians: Initial evaluation of the patient with
lung cancer: Symptoms, signs, laboratory tests, and paraneoplastic
syndromes: ACCP evidenced-based clinical practice guidelines (2nd
edition). Chest. 132(Suppl 3): 149S–160S. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ost D, Fein AM and Feinsilver SH: Clinical
practice. The solitary pulmonary nodule. N Engl J Med.
348:2535–2542. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fujimoto K: Usefulness of
contrast-enhanced magnetic resonance imaging for evaluating
solitary pulmonary nodules. Cancer Imaging. 8:36–44. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Webb WR, Gatsonis C, Zerhouni EA, Heelan
RT, Glazer GM, Francis IR and McNeil BJ: CT and MR imaging in
staging non-small cell bronchogenic carcinoma: Report of the
Radiologic Diagnostic Oncology Group. Radiology. 178:705–713. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bergin CJ, Glover GH and Pauly JM: Lung
parenchyma: Magnetic susceptibility in MR imaging. Radiology.
180:845–848. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Suga K, Ogasawara N, Okada M, Hara A and
Matsunaga N: Potential of noncontrast electrocardiogram-gated
half-Fourier fast-spin-echo magnetic resonance imaging to monitor
dynamically altered perfusion in regional lung. Invest Radiol.
37:615–625. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sartori S, Postorivo S, Vece FD, Ermili F,
Tassinari D and Tombesi P: Contrast-enhanced ultrasonography in
peripheral lung consolidations: What's its actual role? World J
Radiol. 5:372–380. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
van de Luijtgaarden ACI, de Rooy JW, de
Geus-Oei LF, van der Graaf WT and Oyen WJ: Promises and challenges
of positron emission tomography for assessment of sarcoma in daily
clinical practice. Cancer Imaging. 8:S61–S68. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sim YT, Goh YG, Dempsey MF, Han S and Poon
FW: PET-CT evaluation of solitary pulmonary nodules: correlation
with maximum standardized uptake value and pathology. Lung.
191:625–632. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
MacManus MP, Hicks RJ, Ball DL, Ciavarella
F, Binns D, Hogg A, Kalff V, Ware R, Wirth A, Salminen E and
McKenzie A: Imaging with F-18 FDG PET is superior to Tl-201 SPECT
in the staging of non-small cell lung cancer for radical radiation
therapy. Australas Radiol. 45:483–490. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang L, Yin X, Wang F, Gu J, Lu L, Wu Q,
Shen B and Li XF: The usefulness of combined diagnostic CT and
(99m)Tc-octreotide somatostatin receptor SPECT/CT imaging on
pulmonary nodule characterization in patients. Cancer Biother
Radiopharm. 28:731–736. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schuurmans MM, Ellmann A, Bouma H, Diacon
AH, Dyckmans K and Bolliger CT: Solitary pulmonary nodule
evaluation with 99mTc-methoxy isobutyl isonitrile in a
tuberculosis-endemic area. Eur Respir J. 30:1090–1095. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Spanu A, Schillaci O, Pirina P, Arru A and
Madeddu G, Chessa F, Marongiu P, Solinas ME and Madeddu G:
99mTc-tetrofosmin SPECT in solitary pulmonary nodule evaluation.
Oncol Rep. 16:763–769. 2006.PubMed/NCBI
|
|
21
|
Liu L, Song Y, Gao S, Ji T, Zhang H, Ji B,
Chen B, Jia B, Wang F, Xu Z and Ma Q: (99)mTc-3PRGD2
scintimammography in palpable and nonpalpable breast lesions. Mol
Imaging. 13:1–7. 2014.PubMed/NCBI
|
|
22
|
Jin X, Meng Y, Zhu Z, Jing H and Li F:
Elevated 99mTc 3PRGD2 activity in benign metastasizing leiomyoma.
Clin Nucl Med. 38:117–119. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang C, Zheng Q and Miao W: Study of
novel molecular probe 99mTc-3PRGD2 in the diagnosis of rheumatoid
arthritis. Nucl Med Commun. 36:1208–1214. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jia B, Liu Z, Zhu Z, Shi J, Jin X, Zhao H,
Li F, Liu S and Wang F: Blood clearance kinetics, biodistribution,
and radiation dosimetry of a kit-formulated integrin αvβ3-selective
radiotracer 99mTc-3PRGD 2 in non-human primates. Mol Imaging Biol.
13:730–736. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou Y, Shao G and Liu S: Monitoring
breast tumor lung metastasis by U-SPECT-II/CT with an integrin
αvβ3-targeted radiotracer 99mTc-3P-RGD2. Theranostics. 2:577–588.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang L, Shi J, Kim YS, Zhai S, Jia B, Zhao
H, Liu Z, Wang F, Chen X and Liu S: Improving tumor-targeting
capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD
dimers with PEG(4) linkers. Mol Pharm. 6:231–245. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang X, Xiong Z, Wu Y, Cai W, Tseng JR,
Gambhir SS and Chen X: Quantitative PET imaging of tumor integrin
alphavbeta3 expression with 18F-FRGD2. J Nucl Med. 47:113–121.
2006.PubMed/NCBI
|
|
28
|
Liu Z, Jia B, Shi J, Jin X, Zhao H, Li F,
Liu S and Wang F: Tumor uptake of the RGD dimeric probe
(99m)Tc-G3-2P4-RGD2 is correlated with integrin αvβ3 expressed on
both tumor cells and neovasculature. Bioconjug Chem. 21:548–555.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Beer AJ, Haubner R, Sarbia M, Goebel M,
Luderschmidt S, Grosu AL, Schnell O, Niemeyer M, Kessler H, Wester
HJ, et al: Positron emission tomography using
[18F]Galacto-RGD identifies the level of integrin α(v)β3
expression in man. Clin Cancer Res. 12:3942–3949. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang X, Cao A, Peng M, Hu C, Liu D, Gu T
and Liu H: The value of chest CT scan and tumor markers detection
in sputum for early diagnosis of peripheral lung cancer. Zhongguo
Fei Ai Za Zhi. 7:58–63. 2004.PubMed/NCBI
|
|
31
|
Maehara Y, Matsumoto M, Matsuura M,
Kawasima M, Tateno K and Sakaino K: Pleural thickening associated
with solitary pulmonary nodule: Evaluation with thin-slice CT.
Nihon Igaku Hoshasen Gakkai Zasshi. 49:253–258. 1989.(In Japanese).
PubMed/NCBI
|
|
32
|
Schwarz C, Schönfeld N, Bittner RC,
Mairinger T, Rüssmann H, Bauer TT, Kaiser D and Loddenkemper R:
Value of flexible bronchoscopy in the pre-operative work-up of
solitary pulmonary nodules. Eur Respir J. 41:177–182. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Midthun DE: Solitary pulmonary nodule:
Time to think small. Curr Opin Pulm Med. 6:364–370. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kim SK, Allen-Auerbach M, Goldin J, Fueger
BJ, Dahlbom M, Brown M, Czernin J and Schiepers C: Accuracy of
PET/CT in characterization of solitary pulmonary lesions. J Nucl
Med. 48:214–220. 2007.PubMed/NCBI
|
|
35
|
Jeong SY, Lee KS, Shin KM, Bae YA, Kim BT,
Choe BK, Kim TS and Chung MJ: Efficacy of PET/CT in the
characterization of solid or partly solid solitary pulmonary
nodules. Lung Cancer. 61:186–194. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Folkman J: Angiogenesis. Annu Rev Med.
57:1–18. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Brooks PC, Clark RA and Cheresh DA:
Requirement of vascular integrin alpha v beta 3 for angiogenesis.
Science. 264:569–571. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mousa SA: Alphav Vitronectin receptors in
vascular-mediated disorders. Med Res Rev. 23:190–199. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Thurston G, Murphy TJ, Baluk P, Lindsey JR
and McDonald DM: Angiogenesis in mice with chronic airway
inflammation: Strain-dependent differences. Am J Pathol.
153:1099–1112. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Antonov AS, Antonova GN, Munn DH, Mivechi
N, Lucas R, Catravas JD and Verin AD: αVβ3 integrin regulates
macrophage inflammatory responses via PI3 kinase/Akt-dependent
NF-κB activation. J Cell Physiol. 226:469–476. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Horton MA: The alpha v beta 3 integrin
‘vitronectin receptor’. Int J Biochem Cell Biol. 29:721–725. 1997.
View Article : Google Scholar : PubMed/NCBI
|
